BACKGROUND: Gene complementation strategies are important in validating the roles of genes in specific phenotypes. Complementation systems in Helicobacter pylori include shuttle vectors, which transform H. pylori at relatively low frequencies, and chromosomally based approaches. Chromosomal complementation strategies are susceptible to polar effects and disruption of other H. pylori genes, leading to unwanted pleiotropic effects. MATERIALS AND METHODS: A new complementation strategy was developed for H. pylori by utilizing a suicide plasmid vector that contains fragments of an H. pylori intergenic region (hp0203-hp0204), a chloramphenicol acetyltransferase cassette (cat), and a multiple-cloning site. Genes of interest could be cloned into the intergenic plasmid and the genes integrated into H. pylori by homologous recombination into the intergenic chromosomal region without disrupting any annotated H. pylori gene. The complementation system was validated using the gene encoding arginase (rocF). RESULTS: A rocF mutant unable to hydrolyze or consume l-arginine regained these functions by complementation with the wild-type rocF gene. Complemented strains also had restored arginase protein as determined by Western blot analysis. The complementation system could be successfully applied to multiple H. pylori strains. The intergenic region varied in length and sequence across 17 H. pylori strains, but the flanking-3' ends of the hp0203 and hp0204 coding regions were highly conserved. Inserting a cat cassette and wild-type rocF into the intergenic region did not alter the ability of strain SS1 to colonize mice. CONCLUSIONS: This complementation strategy should greatly facilitate genetic experiments in H. pylori.
BACKGROUND: Gene complementation strategies are important in validating the roles of genes in specific phenotypes. Complementation systems in Helicobacter pylori include shuttle vectors, which transform H. pylori at relatively low frequencies, and chromosomally based approaches. Chromosomal complementation strategies are susceptible to polar effects and disruption of other H. pylori genes, leading to unwanted pleiotropic effects. MATERIALS AND METHODS: A new complementation strategy was developed for H. pylori by utilizing a suicide plasmid vector that contains fragments of an H. pylori intergenic region (hp0203-hp0204), a chloramphenicol acetyltransferase cassette (cat), and a multiple-cloning site. Genes of interest could be cloned into the intergenic plasmid and the genes integrated into H. pylori by homologous recombination into the intergenic chromosomal region without disrupting any annotated H. pylori gene. The complementation system was validated using the gene encoding arginase (rocF). RESULTS: A rocF mutant unable to hydrolyze or consume l-arginine regained these functions by complementation with the wild-type rocF gene. Complemented strains also had restored arginase protein as determined by Western blot analysis. The complementation system could be successfully applied to multiple H. pylori strains. The intergenic region varied in length and sequence across 17 H. pylori strains, but the flanking-3' ends of the hp0203 and hp0204 coding regions were highly conserved. Inserting a cat cassette and wild-type rocF into the intergenic region did not alter the ability of strain SS1 to colonize mice. CONCLUSIONS: This complementation strategy should greatly facilitate genetic experiments in H. pylori.
Authors: David J McGee; Sateesh Kumar; Ryan J Viator; Jeffrey R Bolland; Julio Ruiz; Domenico Spadafora; Traci L Testerman; David J Kelly; Lewis K Pannell; Henry J Windle Journal: J Biol Chem Date: 2005-12-14 Impact factor: 5.157
Authors: W K Lee; Y S An; K H Kim; S H Kim; J Y Song; B D Ryu; Y J Choi; Y H Yoon; S C Baik; K H Rhee; M J Cho Journal: Appl Environ Microbiol Date: 1997-12 Impact factor: 4.792
Authors: R A Alm; L S Ling; D T Moir; B L King; E D Brown; P C Doig; D R Smith; B Noonan; B C Guild; B L deJonge; G Carmel; P J Tummino; A Caruso; M Uria-Nickelsen; D M Mills; C Ives; R Gibson; D Merberg; S D Mills; Q Jiang; D E Taylor; G F Vovis; T J Trust Journal: Nature Date: 1999-01-14 Impact factor: 49.962
Authors: S Suerbaum; J M Smith; K Bapumia; G Morelli; N H Smith; E Kunstmann; I Dyrek; M Achtman Journal: Proc Natl Acad Sci U S A Date: 1998-10-13 Impact factor: 11.205
Authors: Elizabeth A Trainor; Katherine E Horton; Paul B Savage; Traci L Testerman; David J McGee Journal: Infect Immun Date: 2010-10-25 Impact factor: 3.441
Authors: Olga A Senkovich; Jun Yin; Viktoriya Ekshyyan; Carolyn Conant; James Traylor; Patrick Adegboyega; David J McGee; Robert E Rhoads; Sergey Slepenkov; Traci L Testerman Journal: Infect Immun Date: 2011-05-16 Impact factor: 3.441
Authors: Desirée C Yang; Kris M Blair; Jennifer A Taylor; Timothy W Petersen; Tate Sessler; Christina M Tull; Christina K Leverich; Amanda L Collar; Timna J Wyckoff; Jacob Biboy; Waldemar Vollmer; Nina R Salama Journal: J Bacteriol Date: 2019-06-21 Impact factor: 3.490
Authors: Jennifer A Taylor; Benjamin P Bratton; Sophie R Sichel; Kris M Blair; Holly M Jacobs; Kristen E DeMeester; Erkin Kuru; Joe Gray; Jacob Biboy; Michael S VanNieuwenhze; Waldemar Vollmer; Catherine L Grimes; Joshua W Shaevitz; Nina R Salama Journal: Elife Date: 2020-01-09 Impact factor: 8.140
Authors: François P Douillard; Kieran A Ryan; Michael C Lane; Delphine L Caly; Stanley A Moore; Charles W Penn; Jason Hinds; Paul W O'Toole Journal: BMC Microbiol Date: 2010-04-08 Impact factor: 3.605
Authors: Beth M Carpenter; Timothy K McDaniel; Jeannette M Whitmire; Hanan Gancz; Silvia Guidotti; Stefano Censini; D Scott Merrell Journal: Appl Environ Microbiol Date: 2007-10-05 Impact factor: 4.792